Literature DB >> 27444368

Complementary roles of open and hybrid approaches to thoracoabdominal aortic aneurysm repair.

Ehsan Benrashid1, Hanghang Wang1, Nicholas D Andersen1, Jeffrey E Keenan2, Richard L McCann2, G Chad Hughes3.   

Abstract

OBJECTIVE: Thoracoabdominal aortic aneurysm (TAAA) repair remains a significant challenge with considerable perioperative morbidity and mortality. A hybrid approach utilizing visceral debranching with endovascular aneurysm exclusion has been used to treat high-risk patients and therefore allow repair in more patients. Limited data exist regarding long-term outcomes with this procedure as well as comparison to conventional open repair. This study describes our institutional algorithmic approach to TAAA repair using both open and hybrid techniques.
METHODS: Hybrid and open TAAA repairs performed between July 2005 and August 2015 were identified from a prospectively maintained institutional aortic surgery database. Perioperative morbidity and mortality, freedom from reintervention, and long-term and aorta-specific survival were calculated and compared between the two groups.
RESULTS: During the study period, 165 consecutive TAAA repairs were performed, including 84 open repairs and 81 hybrid repairs. Patients in the hybrid repair group were significantly older, were more frequently female, and had a generally greater comorbid disease burden, including significantly more chronic kidney disease. Despite the older and sicker cohort, there was no difference in in-hospital mortality between the two groups (9.9% hybrid vs 7.1% open; P = .59). Major morbidity rates differed by procedure, with patients undergoing open repair having a significantly higher rate of postoperative stroke (9.5% open vs 0% hybrid; P = .017), whereas patients undergoing hybrid repair had a higher rate of new permanent dialysis (14.8% hybrid vs 3.6% open; P = .043). There was no difference between groups in the rate of postoperative permanent paraplegia/paresis (8.3% open vs 7.4% hybrid; P = .294). There was a significantly increased rate of reintervention in the hybrid repair group (12.3% hybrid vs 1.2% open, P = .004), with all hybrid reinterventions performed because of endoleak. One-year survival was similar between groups at 69% in hybrid repairs vs 77% in open repairs. Long-term survival was worse in the hybrid group (5-year survival, 32% hybrid vs 56% open), although late survival appeared to be influenced mainly by comorbid disease burden, given the similar long-term aorta-specific survival between groups.
CONCLUSIONS: Use of an algorithmic approach whereby higher risk patients with TAAA are treated by a hybrid approach and lower risk patients with conventional open repair yields satisfactory short- and long-term outcomes. The availability of multiple options for TAAA repair within a single center likely allows repair in more patients with consequent decrease in the risk of aorta-related death, at the expense of increased reinterventions for endoleak.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27444368      PMCID: PMC5441846          DOI: 10.1016/j.jvs.2016.04.022

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  42 in total

1.  Thoracoabdominal aneurysm repair: hybrid versus open repair.

Authors:  Rajendra Patel; Mark F Conrad; Vikram Paruchuri; Christopher J Kwolek; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2009-07       Impact factor: 4.268

2.  Results with a selective revascularization strategy for left subclavian artery coverage during thoracic endovascular aortic repair.

Authors:  Teng C Lee; Nicholas D Andersen; Judson B Williams; Syamal D Bhattacharya; Richard L McCann; G Chad Hughes
Journal:  Ann Thorac Surg       Date:  2011-07       Impact factor: 4.330

3.  The visceral hybrid repair of thoraco-abdominal aortic aneurysms--a collaborative approach.

Authors:  S L Drinkwater; D Böckler; H Eckstein; N J W Cheshire; D Kotelis; O Wolf; M S Hamady; P Geisbüsch; M Clark; J R Allenberg; J H Wolfe; R G Gibbs; M P Jenkins
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-08-08       Impact factor: 7.069

4.  Total endovascular repair of thoracoabdominal aortic aneurysms.

Authors:  R E Clough; B Modarai; R E Bell; R Salter; T Sabharwal; P R Taylor; T W Carrell
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-12-23       Impact factor: 7.069

Review 5.  Hybrid thoracoabdominal aortic aneurysm repair: concomitant visceral revascularization and endovascular aneurysm exclusion.

Authors:  G Chad Hughes; Richard L McCann
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

6.  Endoleaks after endovascular repair of thoracic aortic aneurysms.

Authors:  Shane S Parmer; Jeffrey P Carpenter; S William Stavropoulos; Ronald M Fairman; Alberto Pochettino; Edward Y Woo; G William Moser; Joseph E Bavaria
Journal:  J Vasc Surg       Date:  2006-09       Impact factor: 4.268

7.  Comparison of attachment site endoleak rates in Dacron versus native aorta landing zones after thoracic endovascular aortic repair.

Authors:  Asvin M Ganapathi; Nicholas D Andersen; Jennifer M Hanna; Jeffrey G Gaca; Richard L McCann; G Chad Hughes
Journal:  J Vasc Surg       Date:  2013-12-19       Impact factor: 4.268

8.  Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes.

Authors:  John A Cowan; Justin B Dimick; Peter K Henke; Thomas S Huber; James C Stanley; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2003-06       Impact factor: 4.268

9.  Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease.

Authors:  E S Crawford; R W DeNatale
Journal:  J Vasc Surg       Date:  1986-04       Impact factor: 4.268

10.  Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair.

Authors:  Scott A Lemaire; Marisa M Jones; Lori D Conklin; Stacey A Carter; Monique D Criddell; Xing Li Wang; Steven A Raskin; Joseph S Coselli
Journal:  J Vasc Surg       Date:  2008-11-22       Impact factor: 4.268

View more
  7 in total

Review 1.  Debranching aortic surgery.

Authors:  Manuel Alonso Pérez; José Manuel Llaneza Coto; José Antonio Del Castro Madrazo; Carlota Fernández Prendes; Mario González Gay; Amer Zanabili Al-Sibbai
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Hybrid aortic repair with antegrade supra-aortic and renovisceral debranching from ascending aorta.

Authors:  José Antonio Del Castro-Madrazo; Margarita Rivas-Domínguez; Carlota Fernández-Prendes; Amer Zanabili Al-Sibbai; José Manuel Llaneza-Coto; Manuel Alonso-Pérez
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 3.  Hybrid thoracoabdominal aortic aneurysm repair: is the future here?

Authors:  Vicente Orozco-Sevilla; Scott A Weldon; Joseph S Coselli
Journal:  J Vis Surg       Date:  2018-03-30

4.  Survival and patient-centered outcome in a disease-based observational cohort study of patients with thoracoabdominal aortic aneurysm.

Authors:  P Chulhi Kang; Matthew A Bartek; Sherene Shalhub; Derek P Nathan; Matthew P Sweet
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

5.  Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections.

Authors:  Evan C Werlin; Smita Kaushik; Warren J Gasper; Megan Hoffman; Linda M Reilly; Timothy A Chuter; Jade S Hiramoto
Journal:  J Vasc Surg       Date:  2019-07-18       Impact factor: 4.268

6.  Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.

Authors:  Ala Elhelali; Niamh Hynes; Declan Devane; Sherif Sultan; Edel P Kavanagh; Liam Morris; Dave Veerasingam; Fionnuala Jordan
Journal:  Cochrane Database Syst Rev       Date:  2021-06-04

7.  Hybrid Management for Supraceliac Aortic Aneurysm in a High-Risk Patient.

Authors:  Jun Seong Kwon; Jeong Kye Hwang; Sun Cheol Park; Sang Dong Kim
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.